tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Akash Tewari, 145 are a BUY (77.96%), 36 are a HOLD (19.35%), 5 are a SELL (2.69%).
Analyst Akash Tewari, currently employed at JEFFERIES, carries an average stock price target met ratio of 59.62% that have a potential upside of 36.34% achieved within 265 days. Previously, Akash Tewari worked at WOLFE.
Akash Tewari’s has documented 355 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 31-Aug-2026.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 6/21/2022. The price target of $42 was fulfilled within 2 days with a profit of $3.11 (8%) receiving and performance score of 39.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Mar-2024
$58
$11.9 (25.81%)
$41
1 months 12 days ago
(29-Jul-2026)
4/5 (80%)
$9.66 (19.98%)
603
Hold Since 06-Dec-2022
$61
$14.9 (32.32%)
$60
1 months 12 days ago
(29-Jul-2026)
9/11 (81.82%)
$12.66 (26.19%)
123
Buy Since 19-Dec-2022
$65
$18.9 (41.00%)
$43
1 months 13 days ago
(28-Jul-2026)
17/18 (94.44%)
$14.5 (28.71%)
408
Buy Since 01-May-2025
$63
$16.9 (36.66%)
$42
1 months 21 days ago
(20-Jul-2026)
29/34 (85.29%)
$11.28 (21.81%)
353
Buy Since 28-May-2025
$62
$15.9 (34.49%)
$61
1 months 28 days ago
(13-Jul-2026)
6/8 (75%)
$10.13 (19.53%)
223
Which stock is Akash Tewari most bullish on?
Which stock is Akash Tewari most reserved on?
What Year was the first public recommendation made by Akash Tewari?
